Antibody-directed metal-organic framework nanoparticles for targeted drug delivery

Tregubov, 2018, Advanced smart nanomaterials with integrated logic-gating and biocomputing: dawn of theranostic nanorobots, Chem. Rev, 118, 10294, 10.1021/acs.chemrev.8b00198 Shevchenko, 2017, Surface plasmon resonance as a tool for investigation of non-covalent nanoparticle interactions in heterogeneous self-assembly & disassembly systems, Biosens. Bioelectron., 88, 3, 10.1016/j.bios.2016.09.042 Maltzahn, 2011, Nanoparticles that communicate in vivo to amplify tumour targeting, Nat. Mater., 10, 545, 10.1038/nmat3049 Hoskins, 1989, Infinite polymeric frameworks consisting of three dimensionally linked rod-like segments, J. Am. Chem. Soc., 111, 5962, 10.1021/ja00197a079 Rowsell, 2005, Strategies for hydrogen storage in metal-organic frameworks, Angew. Chem. Int. Edit., 44, 4670, 10.1002/anie.200462786 Li, 2007, Gas adsorption and storage in metal−organic framework MOF-177, Langmuir, 23, 12937, 10.1021/la702466d Khan, 2013, Adsorptive removal of hazardous materials using metal-organic frameworks (MOFs): a review, J. Hazard. Mater., 244–245, 444, 10.1016/j.jhazmat.2012.11.011 Lee, 2009, Metal–organic framework materials as catalysts, Chem. Soc. Rev., 38, 1450, 10.1039/b807080f Ma, 2009, Enantioselective catalysis with homochiral metal–organic frameworks, Chem. Soc. Rev., 38, 1248, 10.1039/b807083k Böll, 2019, Clinically approved MRI contrast agents as imaging labels for a porous iron‐based MOF nanocarrier: a systematic investigation in a clinical MRI setting, Adv. Ther. Ray Chowdhuri, 2016, Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agent, Dalton Trans, 45, 2963, 10.1039/C5DT03736K Horcajada, 2010, Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging, Nat. Mater., 9, 172, 10.1038/nmat2608 Taherzade, 2017, Application of metal-organic framework nano-mil-100(Fe) for sustainable release of doxycycline and tetracycline, Nanomaterials., 7, 215, 10.3390/nano7080215 Chen, 2019, Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics, Acta Biomater, 86, 406, 10.1016/j.actbio.2019.01.005 Ebrahimi, 2018, Fabrication of a new superparamagnetic metal-organic framework with core-shell nanocomposite structures: characterization, biocompatibility, and drug release study, Mater. Sci. Eng. C., 92, 349, 10.1016/j.msec.2018.07.010 Wu, 2017, Metal-organic framework (MOF)-Based drug/cargo delivery and cancer therapy, Adv. Mater., 29, 10.1002/adma.201606134 Ibrahim, 2017, Anti-cancer drug delivery using metal organic frameworks (MOFs), Curr. Med. Chem., 24, 193, 10.2174/0929867323666160926151216 Liu, 2019, Bioengineering of metal-organic frameworks for nanomedicine, Theranostics, 9, 3122, 10.7150/thno.31918 Li, 1999, Design and synthesis of an exceptionally stable and highly porous metal-organic framework, Nature, 402, 276, 10.1038/46248 Liu, 2019, In situ polymerization on nanoscale metal-organic frameworks for enhanced physiological stability and stimulus-responsive intracellular drug delivery, Biomaterials, 218, 10.1016/j.biomaterials.2019.119365 Forgan, 2014, 1 Roth Stefaniak, 2018, Photo-triggered release of 5-fluorouracil from a MOF drug delivery vehicle, Chem. Commun., 54, 7617, 10.1039/C8CC01601A Luo, 2019, Light‐Induced redox‐responsive smart drug delivery system by using selenium‐containing polymer@MOF shell/core nanocomposite, Adv. Healthc. Mater., 8, 10.1002/adhm.201900406 Wang, 2016, Controllable synthesis of dual-MOFs nanostructures for pH-responsive artemisinin delivery, magnetic resonance and optical dual-model imaging-guided chemo/photothermal combinational cancer therapy, Biomaterials, 100, 27, 10.1016/j.biomaterials.2016.05.027 Zhu, 2016, PPy@MIL-100 nanoparticles as a pH- and Near-IR-Irradiation-Responsive drug carrier for simultaneous photothermal therapy and chemotherapy of cancer cells, ACS Appl. Mater. Interfaces., 8, 34209, 10.1021/acsami.6b11378 Wang, 2016, Magnetically guided delivery of DHA and Fe ions for enhanced cancer therapy based on pH-responsive degradation of DHA-loaded Fe3O4 @C@MIL-100(Fe) nanoparticles, Biomaterials, 107, 88, 10.1016/j.biomaterials.2016.08.039 Cai, 2019, Metal-Organic framework-based stimuli-responsive systems for drug delivery, Adv. Sci., 6, 10.1002/advs.201801526 Sokolov, 2017, Smart materials on the way to theranostic nanorobots: molecular machines and nanomotors, advanced biosensors, and intelligent vehicles for drug delivery, Biochim. Biophys. Acta - Gen. Subj., 1861, 1530, 10.1016/j.bbagen.2017.01.027 Shi, 2018, FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitor, Biomater. Sci., 6, 2582, 10.1039/C8BM00625C Gao, 2017, Controllable synthesis of a smart multifunctional nanoscale metal–organic framework for magnetic resonance/optical imaging and targeted drug delivery, ACS Appl. Mater. Interfaces., 9, 3455, 10.1021/acsami.6b14795 Wang, 2015, A multifunctional metal–organic framework based tumor targeting drug delivery system for cancer therapy, Nanoscale, 7, 16061, 10.1039/C5NR04045K Deng, 2015, Aptamer-Mediated up-conversion core/MOF shell nanocomposites for targeted drug delivery and cell imaging, Sci. Rep., 5, 7851, 10.1038/srep07851 Zhang, 2018, Engineering metal–organic frameworks for photoacoustic imaging-guided chemo-/photothermal combinational tumor therapy, ACS Appl. Mater. Interfaces., 10, 41035, 10.1021/acsami.8b13492 Zhang, 2019, Positive feedback nanoamplifier responded to tumor microenvironments for self-enhanced tumor imaging and therapy, Biomaterials, 216, 10.1016/j.biomaterials.2019.119255 Xue, 2019, Doxorubicin-loaded nanoscale metal–organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy, Biomater. Sci., 7, 4615, 10.1039/C9BM01044K Cai, 2017, Engineering phototheranostic nanoscale metal–organic frameworks for multimodal imaging-guided cancer therapy, ACS Appl. Mater. Interfaces., 9, 2040, 10.1021/acsami.6b11579 Znoyko, 2018, Ultrasensitive quantitative detection of small molecules with rapid lateral-flow assay based on high-affinity bifunctional ligand and magnetic nanolabels, Anal. Chim. Acta., 1034, 161, 10.1016/j.aca.2018.07.012 Nikitin, 2018, Ultrasensitive detection enabled by nonlinear magnetization of nanomagnetic labels, Nanoscale, 10, 11642, 10.1039/C8NR01511B Canfarotta, 2018, Specific drug delivery to cancer cells with double-imprinted nanoparticles against epidermal growth factor receptor, Nano Lett, 18, 4641, 10.1021/acs.nanolett.7b03206 Bin Na, 2009, Inorganic nanoparticles for MRI contrast agents, Adv. Mater., 21, 2133, 10.1002/adma.200802366 Adolphi, 2012, Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI, Contrast Media Mol. Imag., 7, 308, 10.1002/cmmi.499 Zelepukin, 2019, Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth, Nanoscale, 11, 1636, 10.1039/C8NR07730D Shipunova, 2016, MPQ-cytometry: a magnetism-based method for quantification of nanoparticle–cell interactions, Nanoscale, 8, 12764, 10.1039/C6NR03507H Guo, 2018, A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy, Acta Biomater., 80, 308, 10.1016/j.actbio.2018.09.024 Sasikala, 2016, An implantable smart magnetic nanofiber device for endoscopic hyperthermia treatment and tumor-triggered controlled drug release, Acta Biomater., 31, 122, 10.1016/j.actbio.2015.12.015 Chen, 2019, Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia, Acta Biomater., 96, 491, 10.1016/j.actbio.2019.07.017 Inozemtseva, 2018, 175 Chen, 2019, and dose control of drug delivery using noninvasive magnetic stimulation, ACS Nano, 13, 1292 Ulbrich, 2016, Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies, Chem. Rev., 116, 5338, 10.1021/acs.chemrev.5b00589 Chiang, 2018, Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy, Nat. Nanotechnol., 13, 746, 10.1038/s41565-018-0146-7 Yu, 2016, A facile synthesis of superparamagnetic Fe3O4 supraparticles@MIL-100(Fe) core-shell nanostructures: preparation, characterization and biocompatibility, J. Colloid Interface Sci, 461, 173, 10.1016/j.jcis.2015.09.015 Cheng, 2009, Tunable synthesis of carboxyl-functionalized magnetite nanocrystal clusters with uniform size, J. Mater. Chem., 19, 8782, 10.1039/b910832g Xuan, 2009, Tuning the grain size and particle size of superparamagnetic Fe3O4 microparticles, Chem. Mater., 21, 5079, 10.1021/cm901618m Xu, 2012, Magnetite nanocrystal clusters with ultra-high sensitivity in magnetic resonance imaging, ChemPhysChem, 13, 336, 10.1002/cphc.201100548 Horcajada, 2007, Synthesis and catalytic properties of MIL-100(Fe), an iron(III) carboxylate with large pores, Chem. Commun., 100, 2820, 10.1039/B704325B Bellido, 2014, Understanding the colloidal stability of the mesoporous MIL-100(Fe) nanoparticles in physiological media, Langmuir, 30, 5911, 10.1021/la5012555 Zimpel, 2016, Imparting functionality to MOF nanoparticles by external surface selective covalent attachment of polymers, Chem. Mater., 28, 3318, 10.1021/acs.chemmater.6b00180 Abánades Lázaro, 2017, Selective surface PEGylation of uio-66 nanoparticles for enhanced stability, cell uptake, and pH-Responsive drug delivery, Chem, 2, 561, 10.1016/j.chempr.2017.02.005 Bragina, 2019, Analytical platform with selectable assay parameters based on three functions of magnetic nanoparticles: demonstration of highly sensitive rapid quantitation of staphylococcal enterotoxin B in food, Anal. Chem., 91, 9852, 10.1021/acs.analchem.9b01519 Shipunova, 2018, Versatile platform for nanoparticle surface bioengineering based on SiO2 -Binding peptide and proteinaceous barnase*barstar interface, ACS Appl. Mater. Interfaces, 10, 17437, 10.1021/acsami.8b01627 Zelepukin, 2019, Magnetometry based method for investigation of nanoparticle clearance from circulation in a liver perfusion model, Nanotechnology, 30, 10.1088/1361-6528/aafa3a Hermanson, 2013 Bhattacharjee, 2018, Fe3O4 promoted metal organic framework MIL-100(Fe) for the controlled release of doxorubicin hydrochloride, Microporous Mesoporous Mater., 259, 203, 10.1016/j.micromeso.2017.10.020 Zhang, 2015, Facile synthesis of MIL-100(Fe) under HF-free conditions and its application in the acetalization of aldehydes with diols, Chem. Eng. J., 259, 183, 10.1016/j.cej.2014.07.119 Heyn, 1974, The infrared absorption spectrum of dextran and its bound water, Biopolymers, 13, 475, 10.1002/bip.1974.360130304 Lunin, 2019, Synthesis of highly-specific stable nanocrystalline goethite-like hydrous ferric oxide nanoparticles for biomedical applications by simple precipitation method, J. Colloid Interface Sci., 541, 143, 10.1016/j.jcis.2019.01.065 Zhou, 2003, Dysregulation of cellular signaling by HER2/neu in breast cancer, Semin. Oncol., 30, 38, 10.1053/j.seminoncol.2003.08.006 Mackay, 2003, cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells, Oncogene, 22, 2680, 10.1038/sj.onc.1206349 Neidle, 1977, Nucleic acid binding drugs. Part IV. The crystal structure of the anti-cancer agent daunomycin, Biochim. Biophys. Acta - Nucleic Acids Protein Synth., 479, 450, 10.1016/0005-2787(77)90038-7 Anand, 2014, Host–Guest interactions in Fe(III)-trimesate MOF nanoparticles loaded with doxorubicin, J. Phys. Chem. B, 118, 8532, 10.1021/jp503809w Fiallo, 1999, How Fe3+ binds anthracycline antitumour compounds, J. Inorg. Biochem., 75, 105, 10.1016/S0162-0134(99)00040-9 Farhane, 2018, Doxorubicin kinetics and effects on lung cancer cell lines using in vitro Raman micro-spectroscopy: binding signatures, drug resistance and DNA repair, J. Biophotonics, 11 Ispanixtlahuatl-Meráz, 2018, Cell type specific cytoskeleton disruption induced by engineered nanoparticles, Environ. Sci. Nano., 5, 228, 10.1039/C7EN00704C Brodowicz, 1997, Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro, Int. J. Cancer., 73, 875, 10.1002/(SICI)1097-0215(19971210)73:6<875::AID-IJC19>3.0.CO;2-3 Ott, 2012, Promotion of glioblastoma cell motility by enhancer of Zeste Homolog 2 (EZH2) is mediated by AXL receptor kinase, PLoS ONE, 7, e47663, 10.1371/journal.pone.0047663 Wallberg, 2016, Analysis of apoptosis and necroptosis by fluorescence-activated cell sorting, Cold Spring Harb. Protoc., 2016, 10.1101/pdb.prot087387 Sinha, 1990, Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors, Free Radic. Biol. Med., 8, 567, 10.1016/0891-5849(90)90155-C Zhang, 2012, Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells, Biomaterials, 33, 565, 10.1016/j.biomaterials.2011.09.055 Forrester, 1999, Using computerized video time lapse for quantifying cell death of X- irradiated rat embryo cells transfected with c-myc or c-Ha-ras, Cancer Res, 59, 931